Comparative Effectiveness of Symbicort vs. Advair among COPD patients
Study identifier:000152
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A U.S. Retrospective Database Analysis Evaluating the Comparative Effectiveness of Budesonide/Formoterol (BFC) vs. Fluticasone/Salmeterol (FSC) Combination in Patients with COPD.
Medical condition
COPD
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
3000
Study type
Observational
Age
40 Years +
Date
Study Start Date: 01 Aug 2013
Primary Completion Date: 01 Mar 2014
Study Completion Date: 01 Mar 2014
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Feb 2016 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
Healthcore, Inc
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Symbicort BFC patients new to ICS/LABA therapies | - |
| Advair FSC patients new to ICS/LABA therapies. | - |
